← Back
$BNTC All transactions

Benitec Biopharma Inc.

A

$ Value

$0

Shares

35,000

Price

$0

Filed

Dec 3

Insider

Name

Mehta Kishan

Title

CIK

0001850520

Roles

Director

Transaction Details

Transaction Date

2025-12-01

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

35,000

Footnotes

Consists of options to purchase shares of the Issuer's common stock awarded to Mr. Mehta in connection with his role as a member of the Issuer's Board of Directors. Mr. Mehta, as Portfolio Manager for Averill Master Fund, Ltd. and Averill Madison Master Fund, Ltd (the "Funds") is holding such options for the benefit of the Funds, and as such Mr. Mehta disclaims beneficial ownership of such options. The Funds, and Suvretta Capital Management, LLC ("Suvretta Capital"), the investment manager of the Funds, may be deemed to have an indirect pecuniary interest in such options because Suvretta Capital has rights to receive the benefit of director compensation provided in respect of Mr. Mehta's board service. | The stock options will vest on the earlier of the Issuer's next annual stockholders' meeting or December 1, 2026.

Filing Info

Accession No.

0001012975-25-000850

Form Type

4

Issuer CIK

0001808898

Mehta Kishan's History

Date Ticker Type Value
2026-03-17 BHVN G $0
2026-03-17 BHVN G $0
2025-12-01 BNTC A $0
2025-05-05 BHVN A $0

Other Insiders at BNTC (90d)

Insider Bought Sold Last
Mates Sharon 2026-01-22